Department of Colorectal Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China; Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, China.
Department of Rheumatology and Immunology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, China.
Surgery. 2019 Dec;166(6):1048-1054. doi: 10.1016/j.surg.2019.07.016. Epub 2019 Sep 19.
Intestinal inflammation is the predominant contributor to the genesis of postoperative ileus. Janus kinase 1 plays an important role during inflammation. Here, we investigated the role of Janus kinase 1 in postoperative ileus and whether inhibition of Janus kinase 1 could mitigate postoperative ileus.
A mouse model of postoperative ileus was induced by intestinal manipulation. Janus kinase 1 inhibitor GLPG0634 or placebo was administered orally before intestinal manipulation. At the indicated time points post operation, neutrophil infiltration was assessed by immunohistochemistry and enzyme-linked immunosorbent assay; proinflammatory gene expression was quantified by quantitative reverse-transcriptase polymerase chain reaction and enzyme-linked immunosorbent assay; and Janus kinase 1 activation was detected by Western blot. Functional studies were conducted to evaluate intestinal motility.
We found that intestinal manipulation led to marked activation of Janus kinase 1, with increased proinflammatory gene expression and upregulated myeloperoxidase level. Moreover, intestinal manipulation resulted in an impairment of intestinal transit in vivo and inhibition of smooth muscle contractility in vitro. Preoperative administration of GLPG0634 markedly lowered the expression of proinflammatory cytokines, the myeloperoxidase level in the muscularis layer after bowel manipulation, and significantly ameliorated smooth muscle contractile function and intestinal transit ability.
Our data showed that Janus kinase 1 activation mediated intestinal manipulation-induced resident macrophage activation after intestinal manipulation, and subsequent complex inflammatory cascade and gut dysmotility. Janus kinase 1 inhibition appears to be a prospective and convenient approach for the prevention of postoperative ileus.
肠道炎症是术后肠麻痹发生的主要原因。Janus 激酶 1 在炎症过程中发挥着重要作用。在这里,我们研究了 Janus 激酶 1 在术后肠麻痹中的作用,以及抑制 Janus 激酶 1 是否可以减轻术后肠麻痹。
通过肠道操作诱导术后肠麻痹的小鼠模型。在肠道操作前口服给予 Janus 激酶 1 抑制剂 GLPG0634 或安慰剂。术后指定时间点,通过免疫组织化学和酶联免疫吸附试验评估中性粒细胞浸润;通过定量逆转录聚合酶链反应和酶联免疫吸附试验定量促炎基因表达;通过 Western blot 检测 Janus 激酶 1 激活。进行功能研究以评估肠道蠕动。
我们发现肠道操作导致 Janus 激酶 1 明显激活,促炎基因表达增加,髓过氧化物酶水平上调。此外,肠道操作导致体内肠道转运受损和体外平滑肌收缩力抑制。术前给予 GLPG0634 可显著降低促炎细胞因子的表达、肠道操作后肌层中的髓过氧化物酶水平,并显著改善平滑肌收缩功能和肠道转运能力。
我们的数据表明,Janus 激酶 1 激活介导了肠道操作后驻留巨噬细胞的激活,随后是复杂的炎症级联反应和肠道运动障碍。Janus 激酶 1 抑制似乎是预防术后肠麻痹的一种有前景和方便的方法。